High incidence of BRAF  V600 mutation in Indian patients with head and neck cancer.

High incidence of BRAF V600 mutation in Indian patients with head and neck cancer. Front Biosci (Elite Ed). 2018 Jun 01;10:520-527 Authors: Gauthaman A, Moorthy A Abstract In cancer cells, BRAF is frequently mutated at codon 600 (V600) leading to the replacement of valine amino acid with other amino acids. The current study was performed to assess the prevalence of BRAFV600 mutation in Indian patients with head and neck squamous cell carcinoma (HNSCC). Among the patients, 27% were homozygous, and 71% were heterozygous for the mutation and only 2% showed a wild genotype. Since identification of BRAFV600 mutation in cancer patients is used for selection of the therapeutic agents, this study shows that all Indian patients with HNSCCmust be screened for this mutation. PMID: 29772524 [PubMed - in process]
Source: Frontiers in Bioscience - Elite - Category: Biomedical Science Tags: Front Biosci (Elite Ed) Source Type: research

Related Links:

This article is part of a Special Issue entitled: GSK-3 and related kinases in cancer, neurological and other disorders edited by James McCubrey, Agnieszka Gizak and Dariusz Rakus.
Source: Biochimica et Biophysica Acta (BBA) Molecular Cell Research - Category: Molecular Biology Source Type: research
In this study, glioblastoma multiforme (GBM) as well as head and neck squamous cell carcinomas (HNSCC) were examined because of their different mechanisms of spontaneous and treatment-induced immune escape. Effects on gene expression and protein levels were examined. Accompanying assessment of TRP metabolites from treated GBM cell culture supernatants was conducted. Our results show a heterogeneous and inversely correlated expression profile of TRP-metabolizing genes among GBM and HNSCC cells, with low, but inducible IDO1 expression upon IFNγ treatment. TDO2 expression was higher in GBM cells, while genes encoding ky...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
The epidermal growth factor receptor (EGFR) is pivotal for growth of epithelial cells and is overexpressed in several epithelial cancers like head and neck squamous cell carcinoma (HNSCC). EGFR signalling is a...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Tags: Research article Source Type: research
The number of aging cancer patients has increased continuously and will do so further in the future. The immune system of elderly people experiences critical changes over the time. Therefore, tumor-induced cha...
Source: Immunity and Aging - Category: Geriatrics Authors: Tags: Research Source Type: research
ConclusionsPatients with borderline curability criteria treated with curative intent achieved good PFS and OS. ACE ‐27 was an important prognostic factor in this population.
Source: Journal of Medical Imaging and Radiation Oncology - Category: Radiology Authors: Tags: Radiation Oncology —Original Article Source Type: research
We describe a rare case of cutaneous metastases of laryngeal SCC presenting as multiple eruptive keratoacanthoma-like lesions with concomitant scrofuloderma in an area of previous radiotherapy.
Source: Head and Neck Pathology - Category: Pathology Source Type: research
In this study, systemic bioinformatic analysis was carried out on the genome-wide AS events of 555 clinical HNSCC samples from the TCGA database. Firstly, we statistically analyzed the distributions of seven AS event types in HNSCC samples. Then, through univariate survival analysis, we observed the relationship between AS and the prognosis of the disease and found that 437 intersections of AS events were significantly related to overall survival. Among them, 335 cross-genes showed a high degree of consistency in the genes associated with overall survival and recurrence. The overall survival was significantly related to AS...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
ConclusionOur previously published data, alongside those from other reports, indicate that DKK3 may have an additional oncogenic function other than tumor suppression.
Source: Journal of Oral Biosciences - Category: Biomedical Science Source Type: research
Source: Anti-Cancer Agents in Medicinal Chemistry - Category: Cancer & Oncology Authors: Tags: Research article Source Type: research
Baseline tumor size has been reported to be predictive of immune checkpoint inhibitor efficacy in melanoma and lung cancer. We investigated whether pre-treatment tumor size (PTS) is predictive of progression-free survival (PFS) and tumor shrinkage in head and neck squamous cell carcinoma (HNSCC) patients treated with nivolumab.
Source: Auris, Nasus, Larynx - Category: ENT & OMF Authors: Tags: Original article Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Carcinoma | Head and Neck Cancer | HNSCC | India Health | Squamous Cell Carcinoma | Study